Regulus Therapeutics Inc.
RGLSDelisted Jun 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001505512
Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Regulus Therapeutics Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 28 | 25 | −3 |
| Shares | 6.07M | 8.12M | +2.05M (+33.7%) |
| Value | $12.6M | $13.8M | +$1.23M (+9.8%) |
New holders (4)
Institutions that held Regulus Therapeutics Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FMR LLC | 2,195,000 | $3.73M | 0.00% |
| Dimensional Fund Advisors LP | 31,618 | $54.0K | 0.00% |
| HRT Financial LP | 22,735 | $38.0K | 0.00% |
| Advisor Group Holdings, Inc. | 50 | $0 | 0.00% |
Sold out (7)
Institutions that held Regulus Therapeutics Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ikarian Capital, LLC | 105,341 | $217.0K |
| Citadel Advisors LLC | 23,655 | $49.0K |
| Boothbay Fund Management, LLC | 11,583 | $24.0K |
| Virtu Financial LLC | 10,205 | $21.0K |
| Bank of America Corp | 1,001 | $2.00K |
| Simplex Trading, LLC | 527 | $1.00K |
| Citigroup Inc | 8 | $0 |